Hot Products
| Catalog No. | Information |
| CFN90297 | Ganoderic acid LM2 Ganoderic acid LM2 exhibits potent enhancement of ConA-induced mice splenocytes proliferation in vitro. |
| CFN90747 | Ganoderic acid M Ganoderic acid Me and/or ganoderic acid T have obvious action for inhibiting human tumor cell growth or proliferation, at the same time its toxicity for normal cells is low. |
| CFN90293 | Ganoderic acid N 23-Dihydroganoderic Acid N has anticancer effects. |
| CFN93352 | Ganoderic acid R Reference standards. |
| CFN99066 | Ganoderic acid S A novel combination of triterpenoids includes at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS), the composition is suitable for the treatment or prophylaxis of colon cancer, hepatic cancer, breast cancer, lung cancer or leukemia. Ganoderic acid S and Mf induce mitochondria mediated apoptosis in human cervical carcinoma HeLa cells. |
| CFN97426 | Ganoderic acid SZ Reference standards. |
| CFN90298 | Ganoderic acid TN Reference standards. |
| CFN92237 | Ganoderic acid T-Q Ganoderic acid T-Q and TR are two inhibitors of H5N1 and H1N1 NAs. |
| CFN92235 | Ganoderic acid TR Ganoderic acid TR, a new lanostanoid with 5α-reductase inhibitory activity from the fruiting body of Ganoderma lucidum. |
| CFN92996 | Ganoderic acid X Ganoderic acid X is a potential Mdm2 inhibitor(K(i) = 16nM). It is a potential anticancer drug, inhibits topoisomerases and induces apoptosis of cancer cells. |
